CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma LP v. KV Pharmaceuticals Company

1:07-cv-00032

Overview

Case Number 1:07-cv-00032
Filing Date 2007-01-16
Status Terminated
Termination Date 2007-05-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

KV Pharmaceuticals Company NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Purdue Pharma LP NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (6 found):
U.S. Courts: 6
U.S. District Court 2011-02-03
1:11-cv-00766

Purdue Pharma L.P. v. Varam, Inc.

U.S. Family Sibling (["US5508042", "US8309060"])
Status: NYSD
U.S. District Court 2007-09-12
1:07-cv-00549

Purdue Pharma LP v. Apotex Inc.

U.S. Family Sibling (["US5508042"])
Status: DED
U.S. District Court 2007-06-06
1:07-cv-04810

Purdue Pharma L.P. v. KV Pharmaceutical Company

Asserted Patent
Status: NYSD
U.S. District Court 2006-11-09
1:06-cv-13095

Purdue Pharma L.P. v. Mallinckrodt Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2001-08-30
1:01-cv-08177

Purdue Pharma L.P. v. Endo Pharmaceuticals

Asserted Patent
Status: NYSD
U.S. District Court 2001-03-13
1:01-cv-02109

Purdue Pharma L.P. v. Endo Pharmaceuticals

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5508042
Controlled release oxycodone compositions
Filed: 1995-06-06
Issued: 1996-04-16
Expired (Term Ended)
Expires: 2015-06-06
US5656295
Controlled release oxycodone compositions
Filed: 1996-03-19
Issued: 1997-08-12
Expired (Term Ended)
Expires: 2016-03-19
US5549912
Controlled release oxycodone compositions
Filed: 1992-11-25
Issued: 1996-08-27
Expired (Term Ended)
Expires: 2012-11-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

8

Dispositive

1

Granted

0

Denied

0

Pending / Review

8

Motions by Category

Procedural / Extension Motion 4 Motion to Transfer Venue (28 U.S.C. Β§ 1404) 1 Motion to Stay 3

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
Letter to The Honorable Mary Pat Thynge from Andrew A. Lundgren regarding follow up to April 9, 2007 letter (DI 24) concerning pending Motion to Transfer and Pu...
Entry #26 • 2007-04-11 Document →
Motion to Stay Pending / Under Review
ANSWERING BRIEF in Opposition re [28] MOTION to Stay Antitrust Counterclaims filed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP.Reply Br...
Entry #31 • 2007-05-03 Document →
Motion to Stay Pending / Under Review
DECLARATION re [31] Answering Brief in Opposition (Declaration of Richard A. Inz in support of opposition to motion to stay antitrust counterclaims) by Purdue P...
Entry #32 • 2007-05-03 Document →
Motion to Stay Pending / Under Review
MOTION to Stay Antitrust Counterclaims - filed by Actavis Totowa LLC. (Attachments: # (1) Exhibit 1-6# (2) Text of Proposed Order)Motions referred to Mary Pat T...
Entry #28 • 2007-04-19 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to reply or move with respect to Actavis's First Amended Answer and Counterclaims to April 27, 2007 - filed by Purdue Pharmaceut...
Entry #23 • 2007-03-29 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME Counterclaim-Defendants Reply To KV's Answer & Counterclaims (DI #16) to April 27, 2007; and Counterclaim-Defendants Reply ...
Entry #21 • 2007-03-23 Document →

Docket Entries

(42 total)
Pleading / Complaint

COMPLAINT filed against KV Pharmaceuticals Company, Actavis Totowa LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 146061.) - filed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP. (Attachments: # (1) Exhibit A# (2) Civil Cover Sheet # (3) Acknowledgement of Consent Form)(ead)

Entry #1 • 2007-01-16
1

Disclosure Statement pursuant to Rule 7.1 filed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP identifying Pharmaceutical Research Associates Inc. as Corporate Parent for PF Laboratories Inc. (ead)

Entry #2 • 2007-01-16
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead)

Entry #3 • 2007-01-16
1

Report to the Commissioner of Patents and Trademarks for Patent Number(s) 5,508,042; 5,656,295; 5,549,912; (ead)

Entry #4 • 2007-01-17
1

NOTICE of Change of Address by Rodger Dallery Smith, II (Smith, Rodger)

Entry #5 • 2007-01-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc